Pharmaceutical product recall
Source: YouTube · Dr. John Campbell · published Nov 8, 2024 · 17:10
This video reviews a paper by Dr. Peter R. H. and Dr. Peter Parry comparing historical pharmaceutical recalls to current COVID-19 vaccines, highlighting a massive discrepancy in reported deaths and regulatory response 0:55-1:56 3:00-4:04.
Key Takeaways:
• VAERS data shows a huge spike in reported deaths following COVID-19 vaccine rollout, with 26,850 deaths reported in 2021 compared to significantly lower numbers for traditional vaccines 0:55-1:56.
• Historical recalls occurred after far fewer deaths, such as Vioxx (6,639 deaths) and Meridia (94 deaths), whereas COVID-19 vaccines remain on the market despite over 37,544 reported deaths 3:00-4:04.
• Analysis of deaths per million doses indicates COVID-19 vaccines have rates between 18.45 and 26.8, compared to 0.27 for influenza and 0.53 for Hepatitis B vaccines 4:48-6:49.
• The authors define "educated hesitancy" as skepticism based on toxicity concerns and adverse event data, noting particularly high adverse event rates in children under two 8:37-9:46.
• The paper calls for access to raw clinical trial data and increased pharmacovigilance to explain the excess mortality and lack of regulatory action 15:05-16:20.
The speaker encourages viewers to read the paper to understand why established safety thresholds for recalls appear not to be applied to current vaccines 10:50-11:32.
Sources:
- 0:55-1:56 VAERS data comparison showing spike in deaths.
- 3:00-4:04 Historical recalls vs. COVID-19 vaccine death counts.
- 4:48-6:49 Deaths per million doses comparison.
- 8:37-9:46 Concept of "educated hesitancy" and adverse events in children.
- 15:05-16:20 Call for raw data access and transparency.
Generate CPE Credits
Generate a professional CPE document from this video's transcript.
Estimated credit: 0.5 CPE hours
Estimate uses the video runtime (1 hour ≈ 1 CPE, rounded to the nearest 0.5, minimum 0.5, maximum 2.0). The final amount can be lower after review, never higher.
Topic: Compliance & GRC. Commonly maps to: Security and Risk Management, Asset Security. Exact CISSP domains are assigned during generation.
Free account. One generation at a time, with a daily limit.
CPEBuddy is independent and not affiliated with or endorsed by ISC2, ISACA, or any certification body. Exports are formatted for common CPE submissions; acceptance is at your certification body's discretion.
Transcript Preview
First 800 characters of the transcript
hello War welcome to this talk now in this video we're going to be looking at withdrawal of pharmaceutical products and we're going to look at various pharmaceutical products that have been withdrawn over the past decades and compare that to the current situation and we'll see that there's marked differences between the two now this is based on this paper here pharmaceutical product recall and educated hesitancy towards new drugs and novel Vines and it's by Dr Peter rhs and Dr Peter Parry now Dr Parry I've had the privilege of talking to in the UK and in Australia and uh he's an he's a psychiatrist and Dr rhs is an athetist and intensivist so both practicing clinicians now just to see if you want to watch this let me just give you an inkling of what this video is going to be about so here …